…will offer LSD to researchers at no cost
Carey Turnbull… [of Freedom to Operate & took Compass Pathways to court over patents] announced… achieved Current Good Manufacturing Practices (CGMP) standards from the U.S. Food and Drug Administration (FDA) for its LSD and will offer the drug at no cost to qualified researchers.
The last FDA approved study of LSD in patients ended in 1980, and new studies are set to take place at New York University’s Langone’s Center for Psychedelic Medicine and John Hopkins’ Center for Psychedelics and Consciousness Research.
Original Article (West Fair Online):
Greenwich’s Ceruvia Lifesciences will offer LSD to researchers at no cost
Artwork Fair Use: Alexis